Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0CH0K
|
||||
Former ID |
DNC013998
|
||||
Drug Name |
1-(5-(pyridin-2-yl)oxazol-2-yl)octadec-9-en-1-one
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529594] | ||
Structure |
Download2D MOL |
||||
Formula |
C26H38N2O2
|
||||
Canonical SMILES |
CCCCCCCCC=CCCCCCCCC(=O)C1=NC=C(O1)C2=CC=CC=N2
|
||||
InChI |
1S/C26H38N2O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-20-24(29)26-28-22-25(30-26)23-19-17-18-21-27-23/h9-10,17-19,21-22H,2-8,11-16,20H2,1H3/b10-9-
|
||||
InChIKey |
MTEOAQVTLKPFRA-KTKRTIGZSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [529594] | |
BioCyc Pathway | Anandamide degradation | ||||
KEGG Pathway | Retrograde endocannabinoid signaling | ||||
PANTHER Pathway | Anandamide degradation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.